Cardinal Health completes acquisition of the Harvard Drug Group for $1.115 billion
Cardinal Health announced completion of the acquisition of The Harvard Drug Group, a distributor of generic pharmaceuticals, OTC medications and related products, owned by Court Square Capital Partners. The $1.115 billion acquisition was an all-cash transaction. July 06, 2015